Aveanna initiated with a Sell at UBS

UBS initiated coverage of Aveanna with a Sell rating and $1.50 price target. The analyst believes the company has a “limited ability to generate free cash flow” in the near to medium term, and does not see “significant opportunities to further flex the cost structure to get higher margins.”